Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells

Molecular Brain Research

Volumn 58, Issue 1-2, 1998, Pages 95-102

  Asghari, Vida ^a   Wang, Jun Feng ^a   Reiach, James S ^a   Young, L Trevor ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Activity protein 1 binding; Bipolar disorder; c Fos; c Jun; Fos related antigen; Lithium chloride; Sodium valproate

Indexed keywords

DNA; LITHIUM CHLORIDE; ONCOPROTEIN; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MANIC DEPRESSIVE PSYCHOSIS; NEUROBLASTOMA CELL; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN INDUCTION;

ANTIMANIC AGENTS; BASE SEQUENCE; BINDING SITES; CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KINETICS; LITHIUM CHLORIDE; NEUROBLASTOMA; NUCLEAR PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0032528112     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00107-7     Document Type: Article

References (38)

1. A.T. Arenander, J. de Vellis, H.R. Herschman, Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters, J. Neurosci. Res. 24 (1) (1989) 107-114.
2. D. Bohmann, T.J. Bos, A. Admon, T. Nishimura, P.K. Vogt, R. Tjian, Human protooncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1, Science 238 (1987) 1386-1392.
3. C.L. Bowden, in: A.F. Schatzberg, C.B. Nemeroff (Eds.), Textbook of Psychopharmacology, APA Press, Washington, DC, 1995, pp. 603-614.
4. M.M. Bradford, A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-252.
5. B.P. Bullock, G.P. McNeil, P.R. Dobner, Synergistic induction of neurotensin gene transcription in PC12 cells parallels changes in AP-1 activity, Mol. Brain Res. 27 (1994) 232-242.
6. G. Chen, H.K. Manji, Inhibition of glycogen synthase kinase-3 by the anticonvulsant and antimanic agent valproic acid, Soc. Neurosci. Abstr. (1997) 276.1.
7. G. Chen, H.K. Manji, C.B. Wright, D.B. Hawver, W.Z. Potter, Effects of valproic acid on β-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells, Neuropsychopharmacology 15 (1996) 271-280.
8. J. Chen, M.B. Kelz, B.T. Hope, Y. Nakabeppu, E.J. Nestler, Chronic Fos-related antigens: stable variants of ΔFosB induced in brain by chronic treatments, J. Neurosci. 17 (13) (1997) 4933-4941.
9. G. Chen, P. Yuan, D.B. Hawyer, W.Z. Potter, H.K. Manji, Increase in AP-1 transcription factor DNA binding activity by valproic acid, Neuropsychopharmacology 15 (1997) 272-280.
10. i-protein α-subunit in rat cerebral cortex, Proc. Natl. Acad. Sci. USA 88 (1991) 10634-10637.
11. F.M. Cutrer, V. Limmroth, G. Ayata, M.A. Moskowitz, Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin, Br. J. Pharmacol. 116 (8) (1995) 3199-3204.
12. M.M. Divish, G. Sheftel, A. Boyle, V.D. Kalasapudi, D.F. Papolos, Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action, J. Neurosci. Res. 28 (1991) 40-48.
13. V.C. Foletta, Transcription factor AP-1, and the role of FRA-2, Immunol. Cell Biol. 74 (1996) 121-133.
14. F.K. Goodwin, K.R. Jamison, Manic Depressive Illness, Oxford Univ. Press, Oxford, 1990.
15. B.T. Hope, B. Kosofsky, S.E. Hyman, E.J. Nestler, Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine, Proc. Natl. Acad. Sci. USA 89 (1992) 5764-5768.
16. B.T. Hope, M.B. Kelz, R.S. Duman, E.J. Nestler, Chronic electro-convulsive (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics, J. Neurosci. 14 (1994) 4318-4328.
17. B.T. Hope, H.E. Nye, M.B. Kelz, D.W. Self, M.J. Iadorola, Y. Nakabeppu, R.S. Duman, E.J. Nestler, Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments, Neuron 13 (1994) 1235-1244.
18. C.J. Hudson, L.T. Young, P.P. Li, J.J. Warsh, CNS transmembrane signal transduction in the pathophysiology and pharmacology of affective disorders and schizophrenia, Synapse 13 (1993) 278-293.
19. P. Hughes, M. Dragunow, Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system, Pharmacol. Rev. 47 (1) (1995) 133-178.
20. R.S. Jope, T. Unlap, Dexamethasone attenuates kinase-induced AP-1 activation in rat brain, Mol. Brain Res. 24 (1994) 275-282.
21. V.D. Kalasapudi, G. Sheftel, M.M. Divish, D.F. Papolos, H.M. Lachman, Lithium augments fos protooncogene expression in PC12 pheochromocytoma cells: implications for therapeutic action of lithium, Brain Res. 521 (1990) 47-54.
22. P.S. Klein, D.A. Melton, A molecular mechanism for the effect of lithium on development, Proc. Natl. Acad. Sci. USA 93 (1996) 8455-8459.
23. R.A. Leslie, J.M. Moorman, D.G. Grahame-Smith, Lithium enhances 5-HT2A receptor mediated c-fos expression in rat cerebral cortex, NeuroReport 5 (1993) 241-244.
24. P.P. Li, D. Sibony, M. Green, J.J. Warsh, Lithium modulation of the phosphoinositide signalling system in rat cortex: selective effects on phorbol ester binding, J. Neurochem. 61 (1993) 1722-1730.
25. P.P. Li, L.T. Young, Y.K. Tam, D. Sibony, J.J. Warsh, Effects of chronic lithium and carbamazepine treatment on G-protein subunit expression in rat cerebral cortex, Biol. Psychol. 34 (1993) 167-170.
26. H. Manji, W.A. Potter, R.H. Lenox, Molecular targets for lithium's actions, Arch. Gen. Psychiatry 52 (1995) 531-543.
27. H.K. Manji, G. Chen, H. Shimon, J.K. Hsiao, W.Z. Potter, R.H. Belmaker, Guanine nucleotide-binding proteins in bipolar affective disorder, Arch. Gen. Psychiatry 52 (1995) 135-144.
28. A.A. Mathe, J.C. Miller, C. Stenfors, Chronic dietary lithium inhibits basal c-fos mRNA expression in rat brain, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 19 (1995) 1177-1187.
29. J.C. Miller, A.A. Mathe, Basal and stimulated c-fos mRNA expression in the rat brain: effect of chronic dietary lithium, Neuropsychopharmacology 16 (1997) 408-418.
30. N. Ozaki, D.-M. Chuang, Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain, J. Neurochem. 69 (1997) 2336-2344.
31. V. Stambolic, L. Ruel, J.R. Woodgett, Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells, Curr. Biol. 6 (1996) 1664-1668.
32. T.R. Tolle, J.M. Castro-Lopes, J. Schadrack, G. Evan, W. Zieglgansberger, Anticonvulsants suppress c-fos protein expression in spinal cord neurons following noxious thermal stimulation, Exp. Neurol. 132 (2) (1995) 271-278.
33. M.T. Unlap, R.S. Jope, Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells, Neuropsychopharmacology 17 (1) (1997) 12-17.
34. J.F. Wang, L.T. Young, Differential display PCR reveals increased expression of 2′, 3′ cyclic nucleotide 3′-phosphodiesterase by lithium, FEBS Lett. 386 (1996) 225-229.
35. J.F. Wang, P.P. Li, J.J. Warsh, L.T. Young, Signal transduction abnormalities in bipolar disorder, in: L.T. Young, R.T. Joffe (Eds.), Bipolar Disorder: Biological Models and Their Clinical Application, Marcel Dekker, New York, 1997, pp. 41-80.
36. M.B. Williams, R.S. Jope, Distinctive rat brain immediate-early gene responses to seizures induced by lithium plus pilocarpine, Mol. Brain Res. 25 (1994) 80-89.
37. B.C. Wlodarczyk, J.C. Craig, G.D. Bennett, J.A. Calvin, R.H. Finnell, Valproic acid-induced changes in gene expression during neurulation in a mouse model, Teratology 54 (6) (1996) 284-297.
38. S.T. Young, L.J. Porrino, M.J. Iadarola, Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors, Proc. Natl. Acad. Sci. USA 88 (1991) 1291-1295.